A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)
Clinical trial NCT05324436 · COMPLETED
Trial details
- NCT number
- NCT05324436
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-08
- Primary completion
- 2023-06-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.